Sort by
Refine Your Search
-
Listed
-
Program
-
Field
-
advanced science and technologies into the therapies and vaccines that matter most. Whether you are in the discovery sciences, ensuring drug safety and efficacy or supporting clinical trials, you will apply
-
an enormous opportunity to guide drug development in a data-driven manner while advancing the science of precision medicine. The scale of this data also means that extracting truly applicable biological and
-
advanced science and technologies into the therapies and vaccines that matter most. Whether you are in the discovery sciences, ensuring drug safety and efficacy or supporting clinical trials, you will apply
-
advanced science and technologies into the therapies and vaccines that matter most. Whether you are in the discovery sciences, ensuring drug safety and efficacy or supporting clinical trials, you will apply
-
, external alliances or committees, consortia and academic relationships. BASIC QUALIFICATIONS PhD in Pharmacometrics, Clinical Pharmacology, Pharmacokinetics, Engineering, Pharmaceutical Sciences, Statistics
-
advanced science and technologies into the therapies and vaccines that matter most. Whether you are in the discovery sciences, ensuring drug safety and efficacy or supporting clinical trials, you will apply
-
advanced science and technologies into the therapies and vaccines that matter most. Whether you are in the discovery sciences, ensuring drug safety and efficacy or supporting clinical trials, you will apply
-
advanced science and technologies into the therapies and vaccines that matter most. Whether you are in the discovery sciences, ensuring drug safety and efficacy or supporting clinical trials, you will apply
-
relationships, biomarker characterization and early clinical trial design Collaborate with research biology in the development of in-vitro assays and in-vivo models to generate data that inform preclinical
-
ROLE SUMMARY At Pfizer we deliver breakthroughs that change patients' lives. In La Jolla, we are dedicated to the development of oncology agents that disrupt cancer biology or redirect the immune